Neurimmune Therapeutics Announces Advancement of Alzheimer's Program into Preclinical Development
Neurimmune Therapeutics AG today announced that, following the successful completion of key research milestones, its lea…
Neurimmune Therapeutics AG today announced that, following the successful completion of key research milestones, its lea…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and a…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and a…
Several American pharmaceutical giants such as Pfizer, Johnson & Johnson or Merck & Co are currently fighting losses in…
InVitria, a leading supplier of performance enhancing cell culture media supplements, to sponsor the 21st Meeting of the…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and a…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes…
More than 150 inventors, technology transfer professionals and industry representatives attended the technology transfer…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and a…
Richter-Helm BioLogics GmbH & Co. KG announces today a technological breakthrough in the field of purification of antibo…